排除鳞状细胞肺癌的患者和那些治疗前有咯血的患者后，贝伐单抗治疗导致的致命率就会下降到1.9%。
By excluding patients with squamous-cell lung cancer and those with hemoptysis prior to treatment, the rate was brought down to 1.9%.
贝伐单抗，也是没有用的情况下鳞状细胞癌，因为它会导致出血，从这种类型的肺癌。
Bevacizumab is also not used in cases of squamous cell cancer, because it leads to bleeding from this type of lung cancer.
与从未吸烟者相比，目前和原来吸烟者患有较其他类型难于治疗的鳞状上皮细胞和小细胞肺癌的比例较高。
Compared to never smokers, current and former smokers had proportionally more squamous cell and small-cell lung cancer, which can be harder to treat than other subtypes.
大部分鳞状细胞癌患者当中没有明确有获益。该药不被批准用于鳞状非小细胞肺癌患者维持治疗。
No benefit was seen among patients with predominantly squamous cell cancer. The drug is not approved for patients with squamous cell non-small cell lung cancer.
他们还指出，4种病理类型肺癌中仅发现小细胞癌和鳞状细胞癌的风险降低。
They also noted that, of the 4 histologic subtypes of lung cancer, the risk reduction was only seen for small cell carcinoma and squamous cell carcinoma.
他们还指出，4种病理类型肺癌中仅发现小细胞癌和鳞状细胞癌的风险降低。
They also noted that, of the 4 histologic subtypes of lung cancer, the risk reduction was only seen for small cell carcinoma and squamous cell carcinoma.
应用推荐